Meininger, Gary E : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (63)
Les plus populaires
Liste
- Liste
- Tableau

1

New AASHTO T336-09 Coefficient of Thermal Expansion Test Method

Tanesi, Jussara, Crawford, Gary, Nicolaescu, Mihai, Meininger, Richard, Gudimettla, Jagan

Journal:

Transportation Research Record Journal of the Transportation Research Board

Année:

2010

Langue:

english

Fichier:

PDF, 758 KB

english, 2010

2

Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution

Gary Meininger, Colleen Hadigan, Michael Laposata, Joanne Brown, Jessica Rabe, Joseph Louca, Negar Aliabadi, Steven Grinspoon

Journal:

Année:

2002

Langue:

english

Fichier:

PDF, 60 KB

english, 2002

3

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

Cefalu, William T, Leiter, Lawrence A, Yoon, Kun-Ho, Arias, Pablo, Niskanen, Leo, Xie, John, Balis, Dainius A, Canovatchel, William, Meininger, Gary

Journal:

Année:

2013

Langue:

english

Fichier:

PDF, 489 KB

english, 2013

4

Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study

Stenlöf, Kaj, Cefalu, William T., Kim, Kyoung-Ah, Jodar, Esteban, Alba, Maria, Edwards, Robert, Tong, Cindy, Canovatchel, William, Meininger, Gary

Journal:

Current Medical Research and Opinion

Année:

2014

Langue:

english

Fichier:

PDF, 737 KB

english, 2014

5

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA 1c value

Krobot, Karl J., Ferrante, Shannon Allen, Davies, Michael J., Seck, Thomas, Meininger, Gary E., Williams-Herman, Debora, Kaufman, Keith D., Goldstein, Barry J.

Journal:

Current Medical Research and Opinion

Année:

2012

Langue:

english

Fichier:

PDF, 208 KB

english, 2012

6

Efficacy and safety of twice-daily treatment with canagliflozin, a sodium glucose co-transporter 2 inhibitor, added on to metformin monotherapy in patients with type 2 diabetes mellitus

Qiu, Rong, Capuano, George, Meininger, Gary

Journal:

Journal of Clinical & Translational Endocrinology

Année:

2014

Langue:

english

Fichier:

PDF, 162 KB

english, 2014

7

Canagliflozin Demonstrates Durable Glycemic Improvements Over 104 Weeks Compared with Glimepiride in Subjects with Type 2 Diabetes Mellitus on Metformin

Leiter, Lawrence A., Langslet, Gisle, Cefalu, William T., Yoon, Kun Ho, Arias, Pablo, Xie, John, Balis, Dainus, Millington, Dawn, Vercruysse, Frank, Canovatchel, William, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 61 KB

english, 2013

8

Index to volume 5

Leiter, Lawrence A., Langslet, Gisle, Cefalu, William T., Yoon, Kun Ho, Arias, Pablo, Xie, John, Balis, Dainus, Millington, Dawn, Vercruysse, Frank, Canovatchel, William, Meininger, Gary

Journal:

Journal of Accounting and Public Policy

Année:

1986

Langue:

english

Fichier:

PDF, 54 KB

english, 1986

9

Canagliflozin (CANA) Added on to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) or Glucagon-like Peptide-1 (GLP-1) Agonists with or Without Other Antihyperglycemic Agents (AHAs) in Type 2 Diabetes Mellitus (T2DM)

Woo, Vincent, Wysham, Carol, Mathieu, Chantal, Desai, Mehul, Alba, Maria, Capuano, George, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 53 KB

english, 2013

10

THE HOSPITAL FOR TROPICAL DISEASES.

Woo, Vincent, Wysham, Carol, Mathieu, Chantal, Desai, Mehul, Alba, Maria, Capuano, George, Meininger, Gary

Journal:

Année:

1921

Langue:

english

Fichier:

PDF, 198 KB

english, 1921

11

ASYLUM REPORTS.

Woo, Vincent, Wysham, Carol, Mathieu, Chantal, Desai, Mehul, Alba, Maria, Capuano, George, Meininger, Gary

Journal:

Année:

1904

Langue:

english

Fichier:

PDF, 213 KB

english, 1904

12

Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) and Pioglitazone (PIO) Over 52 Weeks

Goldenberg, Ronald, Forst, Thomas, Guthrie, Robert, Yee, Jacqueline, Vijapurkar, Ujjwala, Meininger, Gary, Stein, Peter

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 132 KB

english, 2013

13

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial

Neal, Bruce, Perkovic, Vlado, de Zeeuw, Dick, Mahaffey, Kenneth W., Fulcher, Greg, Stein, Peter, Desai, Mehul, Shaw, Wayne, Jiang, Joel, Vercruysse, Frank, Meininger, Gary, Matthews, David

Journal:

American Heart Journal

Année:

2013

Langue:

english

Fichier:

PDF, 262 KB

english, 2013

14

Canagliflozin (CANA), a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor, Improves Glycemia and is Well Tolerated in Type 2 Diabetes Mellitus (T2DM) Subjects With Moderate Renal Impairment

Yale, Jean-Francois, Bakris, George, Xi, Liwen, Figueroa, Kate, Wajs, Ewa, Usiskin, Keith, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2012

Langue:

english

Fichier:

PDF, 79 KB

english, 2012

15

Effects of Canagliflozin Added on to Basal Insulin +/– Other Antihyperglycemic Agents in Type 2 Diabetes

Dumas, Richard, Davies, Melanie, Rosenstock, Julio, Desai, Mehul, Alba, Maria, Capuano, George, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 54 KB

english, 2013

16

Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) Over 52 Weeks

Yale, Jean-Francois, Bakris, George, Cariou, Bertrand, Nieto, Javier, Wajs, Ewa, Figueroa, Katherine, Jiang, Joel, Usiskin, Keith, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 61 KB

english, 2013

17

Canagliflozin (CANA) Lowers A1C and Blood Pressure (BP) Through Weight Loss-Independent (WL-I) and Weight Loss-Associated (WL-A) Mechanisms

Chiasson, Jean-Louis, Wilding, John, Blonde, Lawrence, Polidori, David, Meininger, Gary, Stein, Peter

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 143 KB

english, 2013

18

Lower Blood Pressure (BP) with Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM)

Gilbert, Richard E., Weir, Matthew, Januszewicz, Andrzej, González, Fernando Lavalle, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 51 KB

english, 2013

19

Efficacy and Safety of Canagliflozin (CANA) in Older Subjects with Type 2 Diabetes Mellitus (T2DM)

Harris, Stewart, Sinclair, Alan, Bode, Bruce, Vijapurkar, Ujjwala, Gassmann-Mayer, Cristiana, Fung, Albert, Shaw, Wayne, Usiskin, Keith, Desai, Mehul, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2013

Langue:

english

Fichier:

PDF, 155 KB

english, 2013

20

Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies

Sinclair, Alan, Bode, Bruce, Harris, Stewart, Vijapurkar, Ujjwala, Mayer, Cristiana, Fung, Albert, Shaw, Wayne, Usiskin, Keith, Desai, Mehul, Meininger, Gary

Journal:

BMC Endocrine Disorders

Année:

2014

Langue:

english

Fichier:

PDF, 357 KB

english, 2014

21

Efficacy and Safety of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, Versus Glimepiride in Patients with Type 2 Diabetes on Background Metformin

Leiter, Lawrence A., Cefalu, William T., Niskanen, Leo, Xie, John, Millington, Dawn, Canovatchel, William, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2012

Langue:

english

Fichier:

PDF, 62 KB

english, 2012

22

Glycemic Efficacy of Canagliflozin (CANA) by Baseline A1C and Known Duration of Type 2 Diabetes Mellitus (T2DM)

Leiter, Lawrence A., Blonde, Lawrence, Wilding, John, Cerdas, Sonia, Tong, Cindy, Yee, Jacqueline, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 56 KB

english, 2014

23

Achievement of Diabetes-Related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)

Woo, Vincent, Blonde, Lawrence, Mathieu, Chantal, Yee, Jacqueline, Vijapurkar, Ujjwala, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 162 KB

english, 2014

24

Effect of Canagliflozin (CANA) in Patients With Type 2 Diabetes Mellitus (T2DM) Based on Age and Estimated Glomerular Filtration Rate (eGFR)

Gilbert, Richard, Weir, Matthew R., Fioretto, Paola, Law, Gordon, Usiskin, Keith, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 158 KB

english, 2014

25

Efficacy and Safety of Canagliflozin (CANA) Across a Range of Treatment Paradigms Used in Patients with Type 2 Diabetes Mellitus (T2DM)

Bajaj, Harpreet S., Miller, Eden, Roussel, Ronan, Davies, Michael, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 72 KB

english, 2014

26

Glycemic Efficacy of Canagliflozin (CANA) is Largely Independent of Baseline Beta-Cell Function or Insulin Sensitivity

Zinman, Bernard, Matthews, David, Tong, Cindy, Meininger, Gary, Polidori, David

Journal:

Canadian Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 202 KB

english, 2014

27

Efficacy of Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM) by Baseline Body Mass Index (BMI)

Leiter, Lawrence A., Blonde, Lawrence, Wilding, John, Cerdas, Sonia, Tong, Cindy, Yee, Jacqueline, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 74 KB

english, 2014

28

Effect of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, on measurement of serum 1,5-anhydroglucitol (坎格列净，一种钠-葡萄糖共转运体2抑制剂，对血清1,5-脱水葡萄糖醇测定的影响)

Balis, Dainius A., Tong, Cindy, Meininger, Gary

Journal:

Journal of Diabetes

Année:

2014

Langue:

english

Fichier:

PDF, 94 KB

english, 2014

29

Canagliflozin Provides Durable Glycemic Improvements and Body Weight Reduction Over 104 Weeks Versus Glimepiride in Patients With Type 2 Diabetes on Metformin: A Randomized, Double-Blind, Phase 3 Study

Leiter, Lawrence A., Yoon, Kun-Ho, Arias, Pablo, Langslet, Gisle, Xie, John, Balis, Dainius A., Millington, Dawn, Vercruysse, Frank, Canovatchel, William, Meininger, Gary

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 1.14 MB

english, 2015

30

Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

Neal, Bruce, Perkovic, Vlado, de Zeeuw, Dick, Mahaffey, Kenneth W., Fulcher, Greg, Ways, Kirk, Desai, Mehul, Shaw, Wayne, Capuano, George, Alba, Maria, Jiang, Joel, Vercruysse, Frank, Meininger, Gary,

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 810 KB

english, 2015

31

Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

Weir, Matthew R., Januszewicz, Andrzej, Gilbert, Richard E., Vijapurkar, Ujjwala, Kline, Irina, Fung, Albert, Meininger, Gary

Journal:

Journal of Clinical Hypertension

Année:

2014

Langue:

english

Fichier:

PDF, 347 KB

english, 2014

32

EFFECT OF CANAGLIFLOZIN ON TRIGLYCERIDE-TO-HIGH DENSITY LIPOPROTEIN CHOLESTEROL RATIO, A MARKER OF INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Wyne, Kathleen L., Ziboh, Anita, Vijapurkar, Ujjwala, Davies, Michael, Meininger, Gary

Journal:

Journal of the American College of Cardiology

Année:

2015

Langue:

english

Fichier:

PDF, 246 KB

english, 2015

33

Effects of canagliflozin on body weight and relationship to HbA1cand blood pressure changes in patients with type 2 diabetes

Cefalu, William T., Stenlöf, Kaj, Leiter, Lawrence A., Wilding, John P. H., Blonde, Lawrence, Polidori, David, Xie, John, Sullivan, Daniel, Usiskin, Keith, Canovatchel, William, Meininger, Gary

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 292 KB

english, 2015

34

Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus

Wilding, John P.H., Blonde, Lawrence, Leiter, Lawrence A., Cerdas, Sonia, Tong, Cindy, Yee, Jacqueline, Meininger, Gary

Journal:

Journal of Diabetes and its Complications

Année:

2015

Langue:

english

Fichier:

PDF, 668 KB

english, 2015

35

The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus

Gavin, James R., Davies, Melanie J., Davies, Michael, Vijapurkar, Ujjwala, Alba, Maria, Meininger, Gary

Journal:

Current Medical Research and Opinion

Année:

2015

Langue:

english

Fichier:

PDF, 880 KB

english, 2015

36

Safety and Tolerability of Canagliflozin in Patients With Type 2 Diabetes Mellitus: Pooled Analysis of Phase 3 Study Results

Usiskin, Keith, Kline, Irina, Fung, Albert, Mayer, Cristiana, Meininger, Gary

Journal:

Postgraduate Medicine

Année:

2014

Langue:

english

Fichier:

PDF, 896 KB

english, 2014

37

Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program

Erondu, Ngozi, Desai, Mehul, Ways, Kirk, Meininger, Gary

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 626 KB

english, 2015

38

Alpha 1 -Antitrypsin Deficiency

Shin, Sandra J., Meininger, Gary

Journal:

Boston Medical and Surgical Journal

Année:

2000

Langue:

english

Fichier:

PDF, 237 KB

english, 2000

39

Canagliflozin for the treatment of adults with Type 2 diabetes

Meininger, Gary, Canovatchel, William, Polidori, David, Rosenthal, Norm

Journal:

Diabetes Management

Année:

2015

Langue:

english

Fichier:

PDF, 2.18 MB

english, 2015

40

Differential Effects of Metformin and Exercise on Muscle Adiposity and Metabolic Indices in Human Immunodeficiency Virus-Infected Patients

Driscoll, Susan D., Meininger, Gary E., Ljungquist, Karin, Hadigan, Colleen, Torriani, Martin, Klibanski, Anne, Frontera, Walter R., Grinspoon, Steven

Journal:

Journal of Clinical Endocrinology & Metabolism

Année:

2004

Langue:

english

Fichier:

PDF, 108 KB

english, 2004

41

Renal effects of canagliflozin in type 2 diabetes mellitus

Perkovic, Vlado, Jardine, Meg, Vijapurkar, Ujjwala, Meininger, Gary

Journal:

Current Medical Research and Opinion

Année:

2015

Langue:

english

Fichier:

PDF, 957 KB

english, 2015

42

Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials

Bailey, Robert A., Vijapurkar, Ujjwala, Meininger, Gary, Rupnow, Marcia F.T., Blonde, Lawrence

Journal:

Clinical Therapeutics

Année:

2015

Langue:

english

Fichier:

PDF, 267 KB

english, 2015

43

Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus

Watts, Nelson B., Bilezikian, John P., Usiskin, Keith, Edwards, Robert, Desai, Mehul, Law, Gordon, Meininger, Gary

Journal:

Journal of Clinical Endocrinology & Metabolism

Année:

2015

Langue:

english

Fichier:

PDF, 377 KB

english, 2015

44

Response to Comment on Erondu et al. Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680–1686

Erondu, Ngozi, Desai, Mehul, Ways, Kirk, Meininger, Gary

Journal:

Année:

2016

Langue:

english

Fichier:

PDF, 598 KB

english, 2016

45

Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes and Stage 3 Nephropathy

Yamout, Hala, Perkovic, Vlado, Davies, Melanie, Woo, Vincent, de Zeeuw, Dick, Mayer, Cristiana, Vijapurkar, Ujjwala, Kline, Irina, Usiskin, Keith, Meininger, Gary, Bakris, George

Journal:

American Journal of Nephrology

Année:

2014

Langue:

english

Fichier:

PDF, 491 KB

english, 2014

46

Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeks

Blonde, Lawrence, Stenlöf, Kaj, Fung, Albert, Xie, John, Canovatchel, William, Meininger, Gary

Journal:

Postgraduate Medicine

Année:

2016

Langue:

english

Fichier:

PDF, 853 KB

english, 2016

47

Impact of Age and Estimated Glomerular Filtration Rate on the Glycemic Efficacy and Safety of Canagliflozin: A Pooled Analysis of Clinical Studies

Gilbert, Richard E., Weir, Matthew R., Fioretto, Paola, Law, Gordon, Desai, Mehul, Kline, Irina, Shaw, Wayne, Meininger, Gary

Journal:

Canadian Journal of Diabetes

Année:

2016

Fichier:

PDF, 876 KB

2016

48

Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients

Driscoll, Susan D, Meininger, Gary E, Lareau, Mark T, Dolan, Sara E, Killilea, Kathleen M, Hadigan, Colleen M, Lloyd-Jones, Donald M, Klibanski, Anne, Frontera, Walter R, Grinspoon, Steven K

Journal:

Année:

2004

Langue:

english

Fichier:

PDF, 123 KB

english, 2004

49

Regulation of the Growth Hormone/Insulin-like Growth Factor-I Axis in HIV Disease

Meininger, Gary, Grinspoon, Steven

Journal:

The Endocrinologist

Année:

2001

Langue:

english

Fichier:

PDF, 232 KB

english, 2001

50

Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus

Rosenthal, Norm, Meininger, Gary, Ways, Kirk, Polidori, David, Desai, Mehul, Qiu, Rong, Alba, Maria, Vercruysse, Frank, Balis, Dainius, Shaw, Wayne, Edwards, Robert, Bull, Scott, Di Prospero, Nicholas

Journal:

Annals of the New York Academy of Sciences

Année:

2015

Langue:

english

Fichier:

PDF, 1.71 MB

english, 2015